Comparative in vivo expression of amastigote up regulated Leishmania genes in three different forms of Leishmaniasis
- PMID: 19963076
- DOI: 10.1016/j.parint.2009.11.003
Comparative in vivo expression of amastigote up regulated Leishmania genes in three different forms of Leishmaniasis
Abstract
In Old World Leishmania infections in India, Leishmania donovani is responsible for visceral leishmaniasis (VL) and post kala-azar dermal leishmaniasis (PKDL) while L. tropica is responsible for cutaneous leishmaniasis (CL) in humans. The molecular differences between the two species of Leishmania and within the same species causing distinct pathologies that govern the outcome of infection and pathogenesis in the human host are unknown. Quantitative expression of selected genes was evaluated directly in lesion tissues of VL, PKDL and CL patients. Assessment of in vivo mRNA level highlighted substantial differences in gene expression patterns, providing an indication of the genes involved in pathogenesis in the three different forms of Leishmaniasis.
Similar articles
-
Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.Infect Genet Evol. 2007 Mar;7(2):219-22. doi: 10.1016/j.meegid.2006.09.001. Epub 2006 Oct 5. Infect Genet Evol. 2007. PMID: 17027344
-
Genetic fingerprinting and identification of differentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis.Parasitology. 2008 Jan;135(Pt 1):23-32. doi: 10.1017/S0031182007003484. Epub 2007 Aug 28. Parasitology. 2008. PMID: 17761024
-
Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.J Antimicrob Chemother. 2010 Mar;65(3):496-507. doi: 10.1093/jac/dkp468. Epub 2010 Jan 12. J Antimicrob Chemother. 2010. PMID: 20067981
-
Challenges in the diagnosis of post kala-azar dermal leishmaniasis.Indian J Med Res. 2006 Mar;123(3):295-310. Indian J Med Res. 2006. PMID: 16778312 Review.
-
Post-kala-azar dermal leishmaniasis: recent developments.Int J Dermatol. 2011 Sep;50(9):1099-108. doi: 10.1111/j.1365-4632.2011.04925.x. Int J Dermatol. 2011. PMID: 22126871 Review.
Cited by
-
Protective or Detrimental? Understanding the Role of Host Immunity in Leishmaniasis.Microorganisms. 2019 Dec 13;7(12):695. doi: 10.3390/microorganisms7120695. Microorganisms. 2019. PMID: 31847221 Free PMC article. Review.
-
A Leishmania-specific gene upregulated at the amastigote stage is crucial for parasite survival.Parasitol Res. 2018 Oct;117(10):3215-3228. doi: 10.1007/s00436-018-6020-6. Epub 2018 Aug 14. Parasitol Res. 2018. PMID: 30109416
-
Quantitative monitoring of experimental and human leishmaniasis employing amastigote-specific genes.Parasitology. 2022 Jul;149(8):1085-1093. doi: 10.1017/S0031182022000610. Epub 2022 May 10. Parasitology. 2022. PMID: 35535469 Free PMC article.
-
An In-depth Proteomic Map of Leishmania donovani Isolate from Post Kala-azar Dermal Leishmaniasis (PKDL) Patient.Acta Parasitol. 2022 Jun;67(2):687-696. doi: 10.1007/s11686-021-00511-3. Epub 2022 Jan 12. Acta Parasitol. 2022. PMID: 35020128
-
Determinants for the development of visceral leishmaniasis disease.PLoS Pathog. 2013 Jan;9(1):e1003053. doi: 10.1371/journal.ppat.1003053. Epub 2013 Jan 3. PLoS Pathog. 2013. PMID: 23300451 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources